StimOxyGen
Entity

  • StimOxyGen

    Created in 2021


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    775

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Cromore Rd, United Kingdom

    Coleraine

    United Kingdom

  • Employees

    Scale: 2-10

    Estimated: 6

  • Engaged catalyst

    2
    0 0

  • Added in Motherbase

    1 year, 5 months ago
Description
  • Value proposition

    Improving cancer outcomes by overcoming hypoxia.

    StimOxyGen is a proprietary and world-leading innovative approach to address the global challenge of tumour hypoxia.

    Hypoxia, or lack of oxygen, is a common characteristic of solid tumours that contributes to the failure of many types of cancer treatment, particularly radiotherapy which relies on oxygen for maximum efficacy.

    We can solve this longstanding major unmet clinical need by fueling tumours with oxygen to maximise therapeutic effects of radiotherapy.

    nanotechnology, cancer research, hypoxia, and pancreatic cancer

Catalyst interactions
Catalyst Type Tweets Articles
Cabinet Office
Cabinet Office
Research, National and local authorities
Cabinet Office
Research, National and local authorities 		Other

13 Mar 2025


Maddyness
Maddyness
Media, Newspaper Publishing (Auto)
Maddyness
Media, Newspaper Publishing (Auto) 		Other

17 Mar 2025


Social network dynamics
Similar entities
BETA
Last news
Show all articles